|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Incyte
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Incyte is a drug discovery and development company focused on developing proprietary molecule drugs to treat serious medical needs. The company develops drugs to treat diseases in the areas of oncology, inflammation and diabetes.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: DURECT Corporation
Company Financials: Medivation
Company Financials: Array Biopharma Inc.
Company Financials: Isis Pharmaceuticals, Inc.
Company Financials: Momenta Pharmaceuticals
Company Financials: Genta Incorporated
Company Financials: Idenix Pharmaceuticals, Inc.
Company Financials: Basilea Pharmaceutica
Company Financials: Optimer Pharmaceuticals, Inc.
Company Financials: MDRNA, Inc.
|
|
|
|
